S&P 500

5.431,60

-0,04%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Morphic Holding Inc (MORF)
Morphic Holding Inc (MORF) Notícias

MORF

Morphic (MORF)

Morphic Holding Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:MORF

1 2 3 4 5 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
05/06/2024	20:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MORF	Morphic Holding Inc
05/06/2024	17:41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MORF	Morphic Holding Inc
31/05/2024	09:00	GlobeNewswire Inc.	Morphic to Participate in Jefferies Global Healthcare Conference	NASDAQ:MORF	Morphic Holding Inc
21/05/2024	09:00	GlobeNewswire Inc.	Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking Cells	NASDAQ:MORF	Morphic Holding Inc
09/05/2024	17:05	GlobeNewswire Inc.	Morphic to Participate in RBC Capital Markets Global Healthcare Conference	NASDAQ:MORF	Morphic Holding Inc
25/04/2024	08:00	GlobeNewswire Inc.	Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024	NASDAQ:MORF	Morphic Holding Inc
19/03/2024	09:00	GlobeNewswire Inc.	Morphic Appoints Dr. Simon Cooper as Chief Medical Officer	NASDAQ:MORF	Morphic Holding Inc
05/03/2024	18:05	GlobeNewswire Inc.	Morphic to Participate in March Investor Conferences	NASDAQ:MORF	Morphic Holding Inc
22/02/2024	09:46	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:MORF	Morphic Holding Inc
22/02/2024	09:07	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:MORF	Morphic Holding Inc
22/02/2024	09:00	GlobeNewswire Inc.	Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023	NASDAQ:MORF	Morphic Holding Inc
03/01/2024	18:05	GlobeNewswire Inc.	Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:MORF	Morphic Holding Inc
10/11/2023	10:00	GlobeNewswire Inc.	Morphic to Present at November Investor Conferences	NASDAQ:MORF	Morphic Holding Inc
03/11/2023	08:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MORF	Morphic Holding Inc
03/11/2023	08:00	GlobeNewswire Inc.	Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023	NASDAQ:MORF	Morphic Holding Inc
09/10/2023	09:00	GlobeNewswire Inc.	Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Set	NASDAQ:MORF	Morphic Holding Inc
26/09/2023	17:10	GlobeNewswire Inc.	Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of Absence	NASDAQ:MORF	Morphic Holding Inc
22/09/2023	18:30	GlobeNewswire Inc.	Morphic to Present Positive EMERALD-1 Phase 2a Data for MORF-057 in Patients with Moderate to Severe Ulcerative Colitis in Abstract for UEGW 2023	NASDAQ:MORF	Morphic Holding Inc
07/09/2023	17:24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MORF	Morphic Holding Inc
29/08/2023	09:00	GlobeNewswire Inc.	Morphic Announces Participation in 2023 Wells Fargo Healthcare Conference	NASDAQ:MORF	Morphic Holding Inc
09/08/2023	17:05	GlobeNewswire Inc.	Morphic to Present at the Canaccord Genuity 43rd Annual Growth Conference	NASDAQ:MORF	Morphic Holding Inc
03/08/2023	08:05	GlobeNewswire Inc.	Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2023	NASDAQ:MORF	Morphic Holding Inc
23/06/2023	20:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MORF	Morphic Holding Inc
06/06/2023	17:05	GlobeNewswire Inc.	Morphic to Present at the Jefferies Global Healthcare Conference	NASDAQ:MORF	Morphic Holding Inc
02/06/2023	17:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MORF	Morphic Holding Inc
12/05/2023	09:30	GlobeNewswire Inc.	Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference	NASDAQ:MORF	Morphic Holding Inc
11/05/2023	09:00	GlobeNewswire Inc.	Morphic Presents New Biomarker Data at DDW 2023 Supporting MORF-057 Program in Ulcerative Colitis	NASDAQ:MORF	Morphic Holding Inc
05/05/2023	11:30	GlobeNewswire Inc.	Morphic Therapeutic Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares	NASDAQ:MORF	Morphic Holding Inc
04/05/2023	07:05	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:MORF	Morphic Holding Inc
03/05/2023	01:13	GlobeNewswire Inc.	Morphic Therapeutic Announces Pricing of $240.0 Million Public Offering	NASDAQ:MORF	Morphic Holding Inc